The possible estrogenic effects of tamoxifen on plasma lipids and antithrombin III levels were investigated in 91 breast cancer patients. Mean values of total, HDL and LDL cholesterol, triglycerides, glucose, uric acid, and antithrombin III were evaluated in 55 patients on adjuvant tamoxifen for at least 3 months and compared with those found in 36 patients on no therapy. Total cholesterol, LDL cholesterol, and antithrombin III levels were significantly lower in treated patients (p less than 0.05). Our results support the hypothesis of a partial agonist action of this antiestrogen, although general clinical practice suggests that tamoxifen-related thrombotic events are rare.

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels / G., Bertelli; P., Pronzato; D., Amoroso; M. P., Cusimano; Conte, Pierfranco; G., Montagna; S., Bertolini; R., Rosso. - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - STAMPA. - 12:(1988), pp. 307-310.

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.

CONTE, Pierfranco;
1988

Abstract

The possible estrogenic effects of tamoxifen on plasma lipids and antithrombin III levels were investigated in 91 breast cancer patients. Mean values of total, HDL and LDL cholesterol, triglycerides, glucose, uric acid, and antithrombin III were evaluated in 55 patients on adjuvant tamoxifen for at least 3 months and compared with those found in 36 patients on no therapy. Total cholesterol, LDL cholesterol, and antithrombin III levels were significantly lower in treated patients (p less than 0.05). Our results support the hypothesis of a partial agonist action of this antiestrogen, although general clinical practice suggests that tamoxifen-related thrombotic events are rare.
12
307
310
Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels / G., Bertelli; P., Pronzato; D., Amoroso; M. P., Cusimano; Conte, Pierfranco; G., Montagna; S., Bertolini; R., Rosso. - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - STAMPA. - 12:(1988), pp. 307-310.
G., Bertelli; P., Pronzato; D., Amoroso; M. P., Cusimano; Conte, Pierfranco; G., Montagna; S., Bertolini; R., Rosso
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/738328
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 118
  • ???jsp.display-item.citation.isi??? 119
social impact